• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞典的巴氏涂片筛查与宫颈癌死亡率的变化

Pap smear screening and changes in cervical cancer mortality in Sweden.

作者信息

Mählck C G, Jonsson H, Lenner P

机构信息

Institution of Obstetrics/Gynecology, University of Umeå, Sweden.

出版信息

Int J Gynaecol Obstet. 1994 Mar;44(3):267-72. doi: 10.1016/0020-7292(94)90177-5.

DOI:10.1016/0020-7292(94)90177-5
PMID:7909766
Abstract

OBJECTIVES

Age-adjusted incidence of cervical carcinoma has fallen dramatically in Sweden in recent decades. This investigation is an attempt to evaluate the effectiveness of the gynecologic Pap smear screening program in terms of reduction of mortality from cervical cancer.

METHODS

Cervical cancer mortality trends in relation to age, calendar period, county and degree of screening activities in the population were analyzed. Multiplicative Poisson regression models were utilized. The reduction of mortality was attributed to the activities of cervical screening.

RESULTS

The analysis gave a calculated 53% reduction in cervical cancer mortality (95% confidence limits 23-72%), attributable to screening.

CONCLUSIONS

The study supports the hypothesis that gynecological Pap smear screening has had an important impact on the reduction in cervical cancer mortality.

摘要

目的

近几十年来,瑞典宫颈癌的年龄调整发病率大幅下降。本研究旨在评估妇科巴氏涂片筛查计划在降低宫颈癌死亡率方面的有效性。

方法

分析了宫颈癌死亡率与年龄、日历时间、县以及人群筛查活动程度之间的趋势。采用了乘法泊松回归模型。死亡率的降低归因于宫颈筛查活动。

结果

分析得出,归因于筛查的宫颈癌死亡率计算降低了53%(95%置信区间为23%-72%)。

结论

该研究支持以下假设,即妇科巴氏涂片筛查对降低宫颈癌死亡率产生了重要影响。

相似文献

1
Pap smear screening and changes in cervical cancer mortality in Sweden.瑞典的巴氏涂片筛查与宫颈癌死亡率的变化
Int J Gynaecol Obstet. 1994 Mar;44(3):267-72. doi: 10.1016/0020-7292(94)90177-5.
2
The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.挪威1992 - 2000年宫颈癌筛查项目:巴氏涂片覆盖率及宫颈癌发病率的变化
J Med Screen. 2002;9(2):86-91. doi: 10.1136/jms.9.2.86.
3
Papanicolaou smear screening augmented by a magnified chemiluminescent exam.通过放大化学发光检查增强的巴氏涂片筛查。
Int J Gynaecol Obstet. 1993 Dec;43(3):289-96. doi: 10.1016/0020-7292(93)90518-2.
4
Prevention of carcinoma cervix: role of Pap smear screening.子宫颈癌的预防:巴氏涂片筛查的作用
Nepal Med Coll J. 2003 Dec;5(2):82-6.
5
Monitoring and evaluation of a model demonstration project for the control of cervical cancer in Nakhon Phanom province, Thailand.泰国那空拍侬府宫颈癌控制示范项目的监测与评估
Asian Pac J Cancer Prev. 2007 Oct-Dec;8(4):547-56.
6
Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smears.
Int J Epidemiol. 1995 Apr;24(2):300-7. doi: 10.1093/ije/24.2.300.
7
Knowledge and attitudes about the Pap-smear screening program: a population-based study of women aged 20-59 years.关于巴氏涂片筛查项目的知识与态度:一项基于人群的20至59岁女性研究。
Acta Obstet Gynecol Scand. 2002 Oct;81(10):962-7. doi: 10.1080/j.1600-0412.2002.811011.x.
8
A mobile unit: an effective service for cervical cancer screening among rural Thai women.一个移动单元:泰国农村妇女宫颈癌筛查的有效服务。
Int J Epidemiol. 1999 Feb;28(1):35-9. doi: 10.1093/ije/28.1.35.
9
The postpartum Papanicolaou smear.产后巴氏涂片检查。
J Am Board Fam Pract. 1989 Jan-Mar;2(1):4-9.
10
Cervical cancer screening in Sweden.
Eur J Cancer. 2000 Nov;36(17):2255-9. doi: 10.1016/s0959-8049(00)00320-8.

引用本文的文献

1
Incidence and Survival Trends of Cervical Cancer in Khon Kaen, Thailand.泰国孔敬市宫颈癌的发病率及生存趋势
Asian Pac J Cancer Prev. 2025 Apr 1;26(4):1393-1400. doi: 10.31557/APJCP.2025.26.4.1393.
2
Diagnose earlier, live longer? The impact of cervical and breast cancer screening on life span.早期诊断,寿命更长?宫颈癌和乳腺癌筛查对寿命的影响。
PLoS One. 2022 Jul 20;17(7):e0270347. doi: 10.1371/journal.pone.0270347. eCollection 2022.
3
Cervical Cancer in Khon Kaen, Thailand: Analysis of 1990-2014 Incidence Data and Prediction of Future Trends.
泰国孔敬府的宫颈癌:1990 - 2014年发病率数据分析及未来趋势预测
Asian Pac J Cancer Prev. 2019 Feb 26;20(2):369-375. doi: 10.31557/APJCP.2019.20.2.369.
4
Discriminating high-risk cervical Human Papilloma Virus infections with urinary biomarkers via non-targeted GC-MS-based metabolomics.通过非靶向 GC-MS 代谢组学方法,利用尿液生物标志物鉴别高危型人乳头瘤病毒感染。
PLoS One. 2018 Dec 28;13(12):e0209936. doi: 10.1371/journal.pone.0209936. eCollection 2018.
5
Comparison of human papillomavirus (HPV) detection in urine and cervical swab samples using the HPV GenoArray Diagnostic assay.使用人乳头瘤病毒基因芯片诊断检测法对尿液和宫颈拭子样本中人乳头瘤病毒(HPV)检测的比较。
PeerJ. 2017 Oct 9;5:e3910. doi: 10.7717/peerj.3910. eCollection 2017.
6
When Life Got in the Way: How Danish and Norwegian Immigrant Women in Sweden Reason about Cervical Screening and Why They Postpone Attendance.当生活成为阻碍:瑞典的丹麦和挪威移民女性如何看待宫颈癌筛查以及她们推迟筛查的原因
PLoS One. 2015 Jul 9;10(7):e0107624. doi: 10.1371/journal.pone.0107624. eCollection 2015.
7
Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 years.基于诊所的宫颈癌筛查依从性的障碍与促进因素:对23至60岁女性的人群队列研究
PLoS One. 2015 May 26;10(5):e0128270. doi: 10.1371/journal.pone.0128270. eCollection 2015.
8
PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study.PAX1/SOX1 DNA甲基化与宫颈癌前病变检测:台湾妇科肿瘤学组(TGOG)研究
Cancer Med. 2014 Aug;3(4):1062-74. doi: 10.1002/cam4.253. Epub 2014 May 3.
9
Perceptions of risk and barriers to cervical cancer screening at Moi Teaching and Referral Hospital (MTRH), Eldoret, Kenya.肯尼亚埃尔多雷特市莫伊教学与转诊医院(MTRH)对宫颈癌筛查的风险认知及障碍
Afr Health Sci. 2011 Mar;11(1):58-64.
10
Generational risks for cancers not related to tobacco, screening, or treatment in the United States.美国非烟草相关癌症、筛查和治疗的代际风险。
Cancer. 2010 Feb 15;116(4):940-8. doi: 10.1002/cncr.24747.